Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Folks, I am as frustrated as anyone about SP, but let's remember

While I understand what you're saying, I think you miss my point.

Unless they read this forum, or perhaps others, how much digging would a prospective investor (who would probably be buying on the momentum on 4/10 anyway) have to do to discover the re-exams? And how much weight will that carry compared to recognition of 37+ licensees, and big money coming in?

Again, we here are far too close to this thing. Consider this: do you know of a single long that has sold any shares purely due to concerns over the re-exams? One? I'll go a step farther, do you of any longs that have withheld buying purely because of the re-exams (here you may hit paydirt)? IMO, everybody is looking to April, and wondering how big the revenues/profit will be and whether our trend will continue. That's the current gamble. The re-exams and the M&A - those are the follow-on gambles. Those followed by "will our acquisition succeed?", etc.

JMHOs,

SGE

Share
New Message
Please login to post a reply